Cargando…

Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment

This report describes a case of central serous chorioretinopathy (CSCR) occurring following cessation of terbinafine treatment. A 51-year-old man presented for a routine ophthalmic examination. He was treated with oral terbinafine for onychomycosis up to 3 months before the presentation. Spectral-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Shmueli, Or, Nitzan, Itay, Averbukh, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634349/
https://www.ncbi.nlm.nih.gov/pubmed/36341040
http://dx.doi.org/10.1159/000527379
_version_ 1784824468068106240
author Shmueli, Or
Nitzan, Itay
Averbukh, Edward
author_facet Shmueli, Or
Nitzan, Itay
Averbukh, Edward
author_sort Shmueli, Or
collection PubMed
description This report describes a case of central serous chorioretinopathy (CSCR) occurring following cessation of terbinafine treatment. A 51-year-old man presented for a routine ophthalmic examination. He was treated with oral terbinafine for onychomycosis up to 3 months before the presentation. Spectral-domain optical coherence tomography (OCT) showed extrafoveal subretinal fluid in both eyes with small underlying pigment epithelial detachments. There were no additional relevant findings in the patient history or ocular examination. A diagnosis of CSCR was made. After 10 weeks without treatment, OCT demonstrated almost complete resolution of subretinal fluid in both eyes. The exact key ingredients of the perfect storm leading to CSCR in young, healthy individuals are still unknown. Here, we describe, to our knowledge, the first documented case, where the appearance of CSCR was apparently triggered by cessation of antifungal treatment. This unusual case may provoke further research that will bring us closer to understanding the mechanism behind the appearance of CSCR. It may also widen the scope of the routine anamnesis when dealing with patients newly diagnosed with this enigmatic condition.
format Online
Article
Text
id pubmed-9634349
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-96343492022-11-05 Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment Shmueli, Or Nitzan, Itay Averbukh, Edward Case Rep Ophthalmol Case Report This report describes a case of central serous chorioretinopathy (CSCR) occurring following cessation of terbinafine treatment. A 51-year-old man presented for a routine ophthalmic examination. He was treated with oral terbinafine for onychomycosis up to 3 months before the presentation. Spectral-domain optical coherence tomography (OCT) showed extrafoveal subretinal fluid in both eyes with small underlying pigment epithelial detachments. There were no additional relevant findings in the patient history or ocular examination. A diagnosis of CSCR was made. After 10 weeks without treatment, OCT demonstrated almost complete resolution of subretinal fluid in both eyes. The exact key ingredients of the perfect storm leading to CSCR in young, healthy individuals are still unknown. Here, we describe, to our knowledge, the first documented case, where the appearance of CSCR was apparently triggered by cessation of antifungal treatment. This unusual case may provoke further research that will bring us closer to understanding the mechanism behind the appearance of CSCR. It may also widen the scope of the routine anamnesis when dealing with patients newly diagnosed with this enigmatic condition. The Author(s). Published by S. Karger AG 2022-10-27 /pmc/articles/PMC9634349/ /pubmed/36341040 http://dx.doi.org/10.1159/000527379 Text en © 2022 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Shmueli, Or
Nitzan, Itay
Averbukh, Edward
Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
title Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
title_full Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
title_fullStr Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
title_full_unstemmed Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
title_short Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
title_sort central serous chorioretinopathy development following cessation of terbinafine treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634349/
https://www.ncbi.nlm.nih.gov/pubmed/36341040
http://dx.doi.org/10.1159/000527379
work_keys_str_mv AT shmuelior centralserouschorioretinopathydevelopmentfollowingcessationofterbinafinetreatment
AT nitzanitay centralserouschorioretinopathydevelopmentfollowingcessationofterbinafinetreatment
AT averbukhedward centralserouschorioretinopathydevelopmentfollowingcessationofterbinafinetreatment